| Institution | PI Name | Title |
|---|
PAR-03-025 |
| Affinium Pharmaceuticals, Inc. | Schmid, Molly B | Novel antibacterial agents for treatment of Tularemia |
| Alphavax Human Vaccines, Inc. | Chulay, Jeffrey D | Alphavirus Replicon Vaccines against Botulinum Neurotoxins< |
| Arizona State University | Jacobs, Bertram L | Development of a Safer Smallpox Vaccine |
| Biolog, Inc. | Bochner, Barry R | Detection of Bioterrorism Agents with PM Technology |
| Callida Genomics | Drmanac, Radoje | Comprehensive pathogen diagnostics with rSBH system |
| Chimerix, Inc. | Painter, George R | Development of an Oral Drug for Smallpox Treatment |
| Coley Pharmaceutical Group, Inc. | Krieg, Arthur M | Pulmonary innate immune activation for bioterror defense |
| Influx, Inc. | Markham, Penelope N | PTE-based drug for antibiotic-resistant anthrax |
| Molecular Targeting Technology, Inc. | Mattis, Jeffrey, A | Human Mab cocktail for rabies post-exposure prophylaxis |
| Omrix Biopharmaceuticals | Nur, Israel | High Titer VIG for the Treatment of Smallpox |
| Powderject Vaccines, Inc. | Haynes, Joel R | Influenza DNA Vaccine for Biodefense/Pandemic Readiness |
| Sequella, Inc. | Nacy, Carol A | A Second-Generation Patch Test for the Diagnosis of Active Tuberculosis |
PAR-02-026 |
| Cambria Biosciences, LLC | Chouinard, Scott W | Insect Glutamate Receptors as Novel Insecticide Targets |
| Chiron Corporation | Pichuantes, Sergio | Development of Rapid Diagnostic Tests for Hantaviruses |
| Diversa Corporation | Kimmel, Bruce E | Characterization of Proteomes of Category A Pathogens |
| Dow Chemical Company | Miller, Barbara A | Non-Invasive Plant Virus Particle-Based Anthrax Vaccines |
| Elusys Therapeutics | Pincus, Steven E | Heteropolymer System to Treat Vaccinia Complications |
| Johns Hopkins University | Dick, James D | Drug Development for MDR-M Tuberculosis |
| Medical College of Wisconsin | Henrickson, Kelly J | Multiplex PCR Detection of CDC 'A' Bioterrorism Agents |
| Medical College of Wisconsin | Traktman, Paula | Inhibiting Poxvirus Phosphatases: Therapy and Biodefense |
| Mithragen, Inc. | Lin, Augustine Y | Development of a Novel Retrogen Vaccine for Anthrax |
| Northeastern Ohio Universities College of Medicine | Rosenthal, Kenneth S | DerG (Immunomodulator) Treatment of Viral Encephalitis |
| Pennsylvania State University | Cameron, Craig E | Lethal Mutagenesis as an Antiviral Strategy |
| University of California - Riverside | Federici, Brian A | Highly Improved Bacterial Larvicides for Vector Control |
| University of Kansas - Lawrence | David, Sunil A | Hydrophobic Polyamine Amides as Anti-Endotoxin Agents |
| University of Pennsylvania | Weiner, David B | Novel Vaccines for Smallpox |
| University of Texas Medical Branch - Galveston | Gorenstein, David G | Biodefense Proteomics Collaboratory |
| University of Virginia - Charlottesville | Obrig, Tom | New Therapeutics for Pathogenic E-coli Diseases |